Genscript USA Inc.

Genscript USA Inc. is a biotechnology company headquartered in Piscataway, New Jersey, specializing in advanced molecular biology services for federal agencies. Registered in the System for Award Management (SAM) since July 2013, the company provides a wide range of scientific products and services, including gene synthesis, gene editing, protein production, antibody development, and custom biological research materials. As a for-profit organization, Genscript has established itself as a critical vendor for federal research institutions, particularly in life sciences and biomedical research domains, supporting various government agencies in their scientific and public health initiatives.

The company has received numerous federal contract awards primarily from health-related agencies, with a significant focus on molecular biology services. Genscript's contract awards span multiple federal agencies, including the National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), Food and Drug Administration (FDA), and Department of Agriculture (USDA). Their services have included custom gene synthesis, protein antigen production, monoclonal and polyclonal antibody development, plasmid preparation, peptide synthesis, and specialized research support for infectious disease research. While most contracts are not set aside, Genscript has received some small business designated awards. The contract values range from approximately $10,000 to over $3 million, demonstrating the company's capability to handle both small and large-scale scientific research support contracts.

Genscript holds a notable blanket purchase agreement (BPA) with the USDA Animal and Plant Health Inspection Service, valued at $1.5 million through August 2024, specifically for SARS-CoV-2 surrogate virus neutralization test kits and associated reagents. Under this BPA, Genscript has received multiple call orders from different USDA sub-agencies, including Wildlife Services and Marketing and Regulatory Programs Business Services. The BPA has been used to support disease monitoring, research, and development efforts, particularly in understanding disease transmission and evaluating control strategies. This IDV highlights Genscript's critical role in supporting federal agencies' rapid response capabilities during emerging infectious disease threats, leveraging their expertise in molecular biology and diagnostic testing.